The HBL-1, HT, TMD8, WSU-DLCL-2 DLBCL cell lines and Karpas-422 NHL cell lines and the Raji Burkitt’s lymphoma cell line all demonstrate phenotypic sensitivity to the GLS inhibitor BPTES (Supplementary Figure 1). This evidence concerns the gene GLS and diffuse large B-cell lymphoma.